To sum up, the above findings point to the conclusion that CSF IL-6 plays a role in NMO immunopathogenesis and is a potential biomarker of diagnosis, disease activity and prognosis [64,65,66,67,68]. The gene discussed is IL6; the disease is neuromyelitis optica.